Progesterone
Luteina is a medicine that contains a synthetically obtained natural female sex hormone, progesterone.
In the body, progesterone acts through specific receptors located in the uterus, breast tissue, central nervous system, and pituitary gland.
The most important effects of progesterone on the reproductive organs are: enabling ovulation, transforming the endometrium (the lining of the uterus) to allow implantation of a fertilized egg, inhibiting excessive growth of the endometrium caused by estrogen, cyclic changes in the epithelium of the fallopian tubes, cervix, and vagina. Progesterone and estrogen also act on the breast tissue, stimulating the growth of glands and ductal epithelium, and enabling lactation.
Progesterone is a hormone necessary for the proper preparation of the endometrium for implantation of the embryo, for the maintenance of pregnancy throughout its duration: it suppresses the spontaneous contractile activity of the pregnant uterus, inhibits the mother's immune response to fetal antigens, is a basic substance for the production of fetal hormones, and initiates labor.
Indications for the use of Luteina:
Before starting to take Luteina, discuss it with your doctor.
This medicine, when used as recommended, does not have a contraceptive effect.
Before starting hormone replacement therapy during menopause (and later at regular annual intervals), you should consult a doctor who will perform a breast and pelvic examination. You should tell your doctor if:
There is a lack of sufficient data on the safety and efficacy of Luteina in children and adolescents.
Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Some medicines may affect the action of Luteina:
Herbal products containing St. John's Wort (Hypericum perforatum) may weaken the action of Luteina.
Luteina may enhance the action of cyclosporine.
Breastfeeding
Fertility
Luteina administered vaginally does not affect the ability to drive and use machines. In case of side effects such as drowsiness, concentration and attention disorders, dizziness, it is not recommended to drive and use machines (see section 4).
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The dosage of progesterone should be determined individually each time, depending on the indications and efficacy of the action. For doses other than 200 mg, vaginal tablets of 50 mg and 100 mg are available.
In in vitro fertilization programs, 200-400 mg of progesterone are used 2 times a day vaginally.
Treatment is continued until the 77th day after embryo transfer.
Termination of therapy should be done by gradually reducing the administered dose of the medicine.
A dose that provides adequate endometrial protection is 200 mg daily for 12 days or 100-200 mg daily in continuous therapy every day.
In the prevention of preterm labor in singleton pregnancies with a short cervix and (or) a history of spontaneous preterm labor, 200 mg of progesterone are used vaginally once a day from about the 20th week of pregnancy to the 34th week of pregnancy.
In recurrent and threatened miscarriages, 200-400 mg of progesterone are used vaginally 2 times a day.
In the case of recurrent miscarriages, progesterone supplementation should be started in the cycle in which pregnancy is planned. Treatment should be continued uninterrupted until the 18th-22nd week of pregnancy.
In the case of threatened miscarriages, progesterone is used uninterrupted until the 22nd week of pregnancy.
Luteina should be placed in the vagina using the enclosed applicator. The applicator enclosed with Luteina is for personal use and is intended for use by one patient only.
In pregnant women, due to the softened cervix, it is recommended to apply the medicine with the index finger.
INSTRUCTIONS FOR USING THE APPLICATOR
If you take more of this medicine than you should, contact your doctor or pharmacist immediately.
Symptoms of overdose that may occur include drowsiness, dizziness, depression.
These symptoms usually resolved on their own after the dose of the medicine was reduced. You should consult your doctor beforehand.
Take the missed dose as soon as you remember, unless it is almost time for the next dose. Do not take a double dose to make up for a missed dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported after the marketing of progesterone vaginal medicines.
Frequency not known(cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Adverse Reaction Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store below 30°C.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
White or off-white round vaginal tablet.
Blister pack containing 10 vaginal tablets.
Box containing 3 blister packs (30 vaginal tablets) or 6 blister packs (60 vaginal tablets) and one applicator marked vaginal applicator 200.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
tel.: +48 22 732 77 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.